CARL ZEISS MEDITEC AG Carl Zeiss Meditec AG Share Price Börse Stuttgart
Equities
AFX
DE0005313704
Advanced Medical Equipment & Technology
|
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
| 83.05 EUR | -0.48% |
|
-9.15% | -15.09% |
| 31/05 | Carl Zeiss Meditec just above annual low - JPMorgan skeptical | DP |
| 31/05 | JPMorgan puts Carl Zeiss Meditec on 'Negative Catalyst Watch' | DP |
| Sales 2024 * | 2.23B 2.42B 203B | Sales 2025 * | 2.51B 2.72B 228B | Capitalization | 7.5B 8.15B 681B |
|---|---|---|---|---|---|
| Net income 2024 * | 255M 277M 23.15B | Net income 2025 * | 312M 339M 28.32B | EV / Sales 2024 * | 3.54 x |
| Net Debt 2024 * | 396M 430M 35.93B | Net Debt 2025 * | 345M 375M 31.32B | EV / Sales 2025 * | 3.13 x |
| P/E ratio 2024 * |
29.4
x | P/E ratio 2025 * |
23.7
x | Employees | - |
| Yield 2024 * |
1.27% | Yield 2025 * |
1.43% | Free-Float | 40.86% |
More Fundamentals
* Assessed data
More news
Latest transcript on Carl Zeiss Meditec AG
More recommendations
More press releases
More news
| 1 week | -9.15% | ||
| Current month | -2.00% | ||
| 1 month | -14.89% | ||
| 3 months | -28.03% | ||
| 6 months | -0.80% | ||
| Current year | -15.09% |
1 week
82.55
92.10
1 month
82.55101.00
3 years
72.72201.80
5 years
67.70201.80
10 years
19.84201.80
| Managers | Title | Age | Since |
|---|---|---|---|
Markus Weber
CEO | Chief Executive Officer | 51 | 31/21/31 |
| Director of Finance/CFO | 59 | 01/18/01 | |
Christian Müller
BRD | Director/Board Member | 57 | 15/09/15 |
| Members of the board | Title | Age | Since |
|---|---|---|---|
Christian Müller
BRD | Director/Board Member | 57 | 15/09/15 |
Karl Lamprecht
CHM | Chairman | 60 | 25/20/25 |
Peter Kameritsch
BRD | Director/Board Member | 55 | 27/21/27 |
| Date | Price | Change |
|---|---|---|
| 04/24/04 | 82.95 | -0.60% |
| 03/24/03 | 83.45 | -2.00% |
| 31/24/31 | 85.15 | -4.38% |
| 30/24/30 | 89.05 | +1.66% |
| 29/24/29 | 87.6 | -2.01% |
Delayed Quote Börse Stuttgart, June 04, 2024 at 05:15 pm IST
More quotes
Carl Zeiss Meditec AG is a Germany-based medical technology and device company. It offers offers complete solutions to diagnose and treat ophtalmic diseases, visualization solutions for microsurgery and other technologies, such as intraoperative radiotherapy. The Company operates in two segments: Ophthalmic Devices and Microsurgery. The Ophthalmic Devices segment comprises activities in the area of ophthalmology, such as intraocular lenses, surgical visualization solutions and medical laser and diagnostic systems. The Microsurgery segment includes activities of neuro, ear, nose and throat surgery, as well as the activities in the field of intraoperative radiation. The Company has various production sites in Europe, the United States and Asia.
Calendar
09/08/2024
- Q3 2024 Earnings Release (Projected)
Related indices
Trading Rating
Investor Rating
ESG Refinitiv
Sell
Buy
Mean consensus
HOLD
Number of Analysts
15
Last Close Price
83.85
EUR
Average target price
103.9
EUR
Spread / Average Target
+23.87%
EPS Revisions
| 1st Jan change | Capi. | |
|---|---|---|
| +7.31% | 217B | |
| +12.99% | 194B | |
| +19.71% | 143B | |
| +30.60% | 111B | |
| +1.67% | 64.3B | |
| +15.23% | 52.94B | |
| +2.06% | 49.53B | |
| -5.49% | 38.31B | |
| -0.22% | 35.22B |
- Stock Market
- Equities
- AFX Stock
- AFX Stock
